Literature DB >> 24311841

A study on the protective effect of Silybum marianum extract on hepatic ischemia-reperfusion injury.

Shaojun Liu1, Zhiheng Chen, Dongbo Cao, Fen Liu, Xiaoyan Wang, Lian Zhao, Rui Liu, Zhiming Xiao.   

Abstract

The objective of the study was to study the protective effect of Silybum marianum extract on hepatic ischemia-reperfusion injury. Rats were randomly divided into five groups; namely Silybum marianum extract high-, medium-, and low-dose protection groups, model group and control group. Hepatic ischemia-reperfusion injury model was prepared. Serum or plasma AST, ALT, MDA, TNF-α, IL-1β, IL-6 levels were measured. The results revealed that after liver injury, AST, ALT, MDA, TNF-α, IL-1β, and IL-6 levels significantly increased in succession, showing significant differences. We concluded that inflammatory cytokines participate in liver injury and that Silybum marianum extract can reduce the production of inflammatory cytokines, and thus can have a protective effect on hepatic ischemia and reperfusion.

Entities:  

Keywords:  Silybum marianum; hepatic ischemia-reperfusion injury; protective effect

Mesh:

Substances:

Year:  2013        PMID: 24311841      PMCID: PMC3847421          DOI: 10.4314/ajtcam.v10i5.14

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  4 in total

1.  [Protective effect of silymarin on liver injury in mice induced by carbon tetrachloride].

Authors:  Run-li Ji; Qing-e Zhao
Journal:  Zhongguo Ying Yong Sheng Li Xue Za Zhi       Date:  2012-05

2.  Antioxidant effect of silymarin on paraquat-induced human lung adenocarcinoma A549 cell line.

Authors:  Biswajit Podder; Yong-Sik Kim; Tamanna Zerin; Ho-Yeon Song
Journal:  Food Chem Toxicol       Date:  2012-06-16       Impact factor: 6.023

3.  Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.

Authors:  Nirav Patel; Cecil Joseph; George B Corcoran; Sidhartha D Ray
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-06       Impact factor: 4.219

4.  Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin.

Authors:  Jong Soon Kang; Young Jin Jeon; Song-Kyu Park; Kyu-Hwan Yang; Hwan Mook Kim
Journal:  Biochem Pharmacol       Date:  2004-01-01       Impact factor: 5.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.